Home LiteratureArticle Details
PMID: 3771794 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndrome.

The Journal of clinical investigation ·Vol. 78 ·No. 5 ·1986-11-00 ·Pages 1229-36

Kannagi M, Kiyotaki M, Desrosiers RC, Reimann KA, King NW, Waldron LM, Letvin NL

Abstract

The T cell tropic retrovirus of macaque monkeys simian T lymphotropic virus type III (STLV-III) has morphologic, growth, and antigenic properties indicating that it is related to human T cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV), the etiologic agent of the acquired immune deficiency syndrome (AIDS) of humans. STLV-III has recently been shown to induce an AIDS-like disease in macaque monkeys. In this study the humoral immune responses of six experimentally infected monkeys have been characterized to determine whether certain parameters of the antibody response to the virus might be predictive of the clinical outcome of this infection. Two distinct patterns of antibody responses were found. Four animals that died within 160 d of inoculation developed low titer anti-STLV-III antibody responses that recognized only the viral envelope protein, and progressive declines in total plasma IgG levels and absolute peripheral blood T4 lymphocyte numbers. The two animals that lived longer (one died at 352 d, the other remains alive at 430 d) developed high titer anti-STLV-III antibody responses that recognized both viral envelope and core proteins, increases in total plasma IgG, and a later decrease in number of peripheral blood T4 lymphocytes. Interestingly, the single animal that has remained clinically healthy after infection was the only one to develop detectable STLV-III neutralizing antibodies.

MeSH Terms
Acquired Immunodeficiency Syndrome/immunology,pathology Animals Antibodies, Viral/analysis Antibody Formation Cerebral Cortex/immunology,pathology Enzyme-Linked Immunosorbent Assay Macaca mulatta Neutralization Tests Retroviridae/immunology,isolation & purification
Chemicals
Antibodies, Viral
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Kannagi M
Kiyotaki M
Desrosiers R C
Reimann K A
King N W
Waldron L M
Letvin N L
References (26)
26 references, click to expand
  1. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  2. Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria.
    Virology. 1986 Apr 15;150(1):283-90 PMID: 3006341
  3. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.
    Science. 1984 May 4;224(4648):506-8 PMID: 6324345
  4. Transmission experiments with human T-lymphotropic retroviruses and human AIDS tissue.
    Lancet. 1984 Jun 23;1(8391):1415-6 PMID: 6145867
  5. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.
    Science. 1984 Jul 20;225(4659):321-3 PMID: 6330889
  6. Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS.
    Science. 1984 Nov 2;226(4674):549-52 PMID: 6093251
  7. Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome.
    Science. 1984 Dec 7;226(4679):1165-71 PMID: 6095449
  8. Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients.
    Lancet. 1985 Jan 5;1(8419):55-6 PMID: 2856985
  9. Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome.
    Am J Med. 1985 Mar;78(3):417-22 PMID: 3872068
  10. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients.
    Science. 1985 May 31;228(4703):1094-6 PMID: 2986291
  11. NIH conference. The acquired immunodeficiency syndrome: an update.
    Ann Intern Med. 1985 Jun;102(6):800-13 PMID: 2986509
  12. Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III.
    Science. 1985 Jun 7;228(4704):1199-201 PMID: 3873705
  13. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques.
    Science. 1985 Jun 7;228(4704):1201-4 PMID: 3159089
  14. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients.
    Nature. 1985 Jul 4-10;316(6023):69-72 PMID: 2989706
  15. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex.
    Nature. 1985 Jul 4-10;316(6023):72-4 PMID: 2989707
  16. Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.
    J Virol. 1985 Aug;55(2):417-23 PMID: 2410630
  17. Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes.
    Proc Natl Acad Sci U S A. 1985 Jul;82(14):4813-7 PMID: 2991896
  18. Genomic diversity of human T-lymphotropic virus type III (HTLV-III).
    Science. 1985 Aug 23;229(4715):759-62 PMID: 2992084
  19. The epidemiology of AIDS: current status and future prospects.
    Science. 1985 Sep 27;229(4720):1352-7 PMID: 2994217
  20. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III.
    Science. 1985 Oct 4;230(4721):71-3 PMID: 2412295
  21. In vitro growth characteristics of simian T-lymphotropic virus type III.
    Proc Natl Acad Sci U S A. 1985 Oct;82(20):7053-7 PMID: 2996002
  22. Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.
    Science. 1985 Nov 22;230(4728):949-51 PMID: 2997922
  23. Immunologic abnormalities in the acquired immunodeficiency syndrome.
    Annu Rev Immunol. 1985;3:477-500 PMID: 2415141
  24. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates.
    J Clin Invest. 1986 Mar;77(3):977-84 PMID: 3081579
  25. Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area.
    Virology. 1986 Apr 15;150(1):1-9 PMID: 3006329
  26. Retrovirus purification: method that conserves envelope glycoprotein and maximizes infectivity.
    J Virol. 1978 Mar;25(3):923-7 PMID: 205680
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1986-11-00
Pages
1229-36
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC423808
Subset
IM
Grants
NIAID NIH HHS · AI20729 · United States
NCI NIH HHS · CA34949 · United States
NCI NIH HHS · CA38205 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com